Your browser doesn't support javascript.
loading
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA.
Ruiz-Bañobre, Juan; Rodriguez-Casanova, Aitor; Costa-Fraga, Nicolas; Bao-Caamano, Aida; Alvarez-Castro, Ana; Carreras-Presas, Martín; Brozos-Vazquez, Elena; Vidal-Insua, Yolanda; Vazquez-Rivera, Francisca; Candamio-Folgar, Sonia; Mosquera-Presedo, Manuel; Lago-Lestón, Ramón M; Muinelo-Romay, Laura; Vázquez-Bueno, José Ángel; Sanz-Pamplona, Rebeca; Moreno, Víctor; Goel, Ajay; Castillo, Lourdes; Martin, Ana C; Arroyo, Rocio; Esteller, Manel; Crujeiras, Ana B; López-López, Rafael; Díaz-Lagares, Angel.
Afiliación
  • Ruiz-Bañobre J; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Rodriguez-Casanova A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, 28029, Madrid, Spain.
  • Costa-Fraga N; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Bao-Caamano A; Roche-Chus Joint Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago (IDIS), 15706, Santiago de Compostela, Spain.
  • Alvarez-Castro A; Universidade de Santiago de Compostela (USC), 15782, Santiago de Compostela, Spain.
  • Carreras-Presas M; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Brozos-Vazquez E; Universidade de Santiago de Compostela (USC), 15782, Santiago de Compostela, Spain.
  • Vidal-Insua Y; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Vazquez-Rivera F; Universidade de Santiago de Compostela (USC), 15782, Santiago de Compostela, Spain.
  • Candamio-Folgar S; Department of Gastroenterology and Hepatology, University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Mosquera-Presedo M; Department of Gastroenterology and Hepatology, University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Lago-Lestón RM; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Muinelo-Romay L; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Vázquez-Bueno JÁ; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Sanz-Pamplona R; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Moreno V; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, 28029, Madrid, Spain.
  • Goel A; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), 15706, Santiago de Compostela, Spain.
  • Castillo L; Universidade de Santiago de Compostela (USC), 15782, Santiago de Compostela, Spain.
  • Martin AC; Liquid Biopsy Analysis Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain.
  • Arroyo R; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, 28029, Madrid, Spain.
  • Esteller M; Liquid Biopsy Analysis Unit, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), 15706, Santiago de Compostela, Spain.
  • Crujeiras AB; Department of Pathology, Complejo Hospitalario Universitario de Ferrol (SERGAS), 15405, Ferrol, Spain.
  • López-López R; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), 08907, Barcelona, Spain.
  • Díaz-Lagares A; Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907, Barcelona, Spain.
Clin Epigenetics ; 14(1): 86, 2022 07 09.
Article en En | MEDLINE | ID: mdl-35810318
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Neoplasias Colorrectales / Pólipos del Colon / Ácidos Nucleicos Libres de Células Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Epigenetics Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Neoplasias Colorrectales / Pólipos del Colon / Ácidos Nucleicos Libres de Células Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Epigenetics Año: 2022 Tipo del documento: Article País de afiliación: España